Pregabalin Administration Reduces the Severity of Neuropathic Pain in Head and Neck Cancer Patients Undergoing Radiotherapy
by dr. Hastarita Lawrenti
| 22 December 2025
Radiotherapy is a mainstay in the management of patients with head and neck cancer, but this therapy is not without complications. One of the side effects is neuropathic pain, which can interfere with quality of life, nutritional status, and adherence to therapy. Clinical trials have shown that pregabalin is beneficial in reducing the severity of radiotherapy-induced neuropathic pain.